Ciprofloxacin Pharmacokinetics in Critically Ill Patients Receiving Concomitant Continuous Venovenous Hemodialysis

被引：7
|
作者：
Shotwell, Matthew S. [1 ]
Madonia, Phillip N. [1 ]
Connor, Michael J. [2 ]
Amde, Milen [3 ]
Salem, Charbel [3 ]
Aduroja, Olufemi A. [3 ]
Bauer, Seth R. [3 ]
Groszek, Joseph J. [1 ]
Fissell, William H. [1 ]
机构：
[1] Vanderbilt Univ, Nashville, TN 37235 USA
[2] Emory Univ, Atlanta, GA 30322 USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2015年 / 66卷 / 01期
关键词：
PSEUDOMONAS-AERUGINOSA; PHARMACODYNAMICS;
D O I：
10.1053/j.ajkd.2015.03.001
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：173 / 175
页数：5
相关论文
共 50 条
  • [21] Population pharmacokinetics of ticarcillin in critically ill patients receiving extended daily diafiltration
    Economou, Caleb J. P.
    Xie, Jiao
    Comadira, Gregory
    Richards, Brent
    Tallott, Mandy
    Wallis, Steven C.
    Ordonez, Jenny
    Lipman, Jeffrey
    Roberts, Jason A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 54 (03) : 351 - 355
  • [22] Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation
    Yang, Seungwon
    Noh, Hayeon
    Hahn, Jongsung
    Jin, Byung Hak
    Min, Kyoung Lok
    Bae, Soo Kyung
    Kim, Jiseon
    Park, Min Soo
    Hong, Taegon
    Wi, Jin
    Chang, Min Jung
    SCIENTIFIC REPORTS, 2017, 7
  • [23] Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal Clearance
    Agyeman, Akosua A.
    Rogers, Kate E.
    Tait, Jessica R.
    Bergen, Phillip J.
    Kirkpatrick, Carl M.
    Wallis, Steven C.
    Bulitta, Jurgen B.
    Paterson, David L.
    Lipman, Jeffrey
    Nation, Roger L.
    Roberts, Jason A.
    Landersdorfer, Cornelia B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (04) : 1104 - 1115
  • [24] Pharmacokinetics and pharmacodynamics of ciprofloxacin in critically ill patients after the first intravenous administration of 400 mg
    Szalek, E.
    Tomczak, H.
    Kaminska, A.
    Grabowski, T.
    Smuszkiewicz, P.
    Matysiak, K.
    Wolc, A.
    Kaczmarek, Z.
    Grzeskowiak, E.
    ADVANCES IN MEDICAL SCIENCES, 2012, 57 (02): : 217 - 223
  • [25] Pharmacokinetics and Pharmacodynamics of Linezolid in Patients With Sepsis Receiving Continuous Venovenous Hemofiltration and Extended Daily Hemofiltration
    Zheng, Junbo
    Sun, Zhidan
    Sun, Lei
    Zhang, Xing
    Hou, Guiying
    Han, Qiuyuan
    Li, Xianghui
    Liu, Gaofeng
    Gao, Yang
    Ye, Ming
    Wang, Hongliang
    Yu, Kaijiang
    JOURNAL OF INFECTIOUS DISEASES, 2020, 221 : S279 - S287
  • [26] The impact of continuous renal replacement therapy on antibiotic pharmacokinetics in critically ill patients
    Fiore, Marco
    Peluso, Lorenzo
    Taccone, Fabio Silvio
    Hites, Maya
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (05) : 543 - 554
  • [27] High-Dose Ciprofloxacin for Serious Gram-Negative Infection in an Obese, Critically III Patient Receiving Continuous Venovenous Hemodiafiltration
    Utrup, Theresa R.
    Mueller, Eric W.
    Healy, Daniel P.
    Callcut, Rachael A.
    Peterson, John D.
    Hurford, William E.
    ANNALS OF PHARMACOTHERAPY, 2010, 44 (10) : 1660 - 1664
  • [28] A personalised approach to antibiotic pharmacokinetics and pharmacodynamics in critically ill patients
    Heffernan, Aaron J.
    Lim, Sazlyna Mohd Sazlly
    Lipman, Jeffrey
    Roberts, Jason A.
    ANAESTHESIA CRITICAL CARE & PAIN MEDICINE, 2021, 40 (06)
  • [29] Pharmacokinetics of free ertapenem in critically ill septic patients: intermittent versus continuous infusion
    Breilh, D.
    Fleureau, C.
    Gordien, J-B
    Joanes-Boyau, O.
    Texier-Maugein, J.
    Rapaport, S.
    Boselli, E.
    Janvier, G.
    Saux, M-C
    MINERVA ANESTESIOLOGICA, 2011, 77 (11) : 1058 - 1062
  • [30] Population pharmacokinetics of daptomycin in critically ill patients
    Soraluce, A.
    Asin-Prieto, E.
    Rodriguez-Gascon, A.
    Barrasa, H.
    Maynar, J.
    Carcelero, E.
    Soy, D.
    Isla, A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (02) : 158 - 165
12345